POSTER, STUDENT POSTER, CLINICAL VIGNETTE … STUDENT POSTER, CLINICAL VIGNETTE POSTER, AND INNOVATION ACADEMY POSTER PRESENTATION INSTRUCTIONS POSTER Viewing: Thursday, ... and pin

POSTER, STUDENT POSTER, CLINICAL VIGNETTE POSTER, AND INNOVATION ACADEMY POSTER

PRESENTATION INSTRUCTIONS

POSTER Viewing: Thursday, April 16 and Friday, April 17 Location: Coles Ballroom (PEI Convention Centre) Viewing Times Thursday April 16:

x Morning break 11:00 am to 12:30 pm o STUDENT POSTER PRESENTERS (SP) MUST

BE AT THEIR POSTERS TO ANSWERS QUESTIONS!

x Lunch between 12:30 pm to 1:00 pm x Welcome Reception 6:30 pm to 8:30 pm

Viewing Times Friday April 17: x Morning break 11:00 am to 12:30 pm

o POSTER (P), CLINICAL VIGNETTE (CV), AND INNOVATION ACADEMY (IA) POSTER PRESENTERS MUST BE AT THEIR POSTERS TO ANSWERS QUESTIONS!

x Lunch between 12:30 pm to 1:00 pm Poster Set-Up Time:

x Wednesday April 15 between 4:00 pm – 6:00 pm x Thursday April 16 between 7:00 am – 10:00 am

Poster Removal Time:

x Friday April 17 at 1:00 pm * Should you require assistance onsite, please go to the Registration Desk. GENERAL INFORMATION

x Poster Boards are 4ft high x 8ft wide. x A good poster size is 3ft high x 6ft wide. x Velcro (male side) and pin friendly.

All presenting authors MUST be registered for the annual conference, no later than Monday March 2, 2015. If registration is not complete by this date, the abstract will be REMOVED and will NOT be published.

STUDENT POSTER Presenters must fill in and submit to ([email protected]) a Student/Technologist/Trainee Awards Competition Form by Monday March 2, 2015. http://ammi.ca/media/75949/Student-Technologist-Trainee%20Award%20Form%20-%20EN%20v2.pdf HOTEL AND CONFERENCE REGISTRATION INFORMATION The Hotel Room Blocks are full at both the Delta Prince Edward and Holman Grand. Please contact Stephanie Wolkowycki at the AMMI Canada Secretariat at [email protected] to make arrangements. REGISTRATION Register now: http://ammi.emsreg.com/ammi15/public/splash1.aspx

STUDENT POSTER PRESENTATION ASSIGNMENT LIST

Serial No. Prog. No. Initial Last name Title

0003 SP01 Bahareh Ghadaki COPD Symptom and Disease Screening in an HIV Population 0004 SP02 Withdrawn

0007 SP03 Gabriel Chan Characterization of Canadian Hospital Infection Control Practices for Caregivers and Visitors

0021 SP04 Chris Lata Antimicrobial Prescribing Practices in the Treatment of Suspected UTI in the Elderly in the Emergency Department: a Retrospective Single Centre Study

0026 SP05 Hong Yuan Zhou The Infectiousness and/or Virulence of Isoniazid-Resistant vs. Susceptible Pulmonary Tuberculosis: A Case-Control Study in Alberta

0028 SP06 Ramzi Fattouh Meropenem MIC Profile of Carbapenemase-Producing Enterobacteriaceae in a Low Prevalence Region

0031 SP07 Nipunie Rajapakse Creation of A Novel Pediatric Antimicrobial Stewardship Advanced Fellowship Training Program

0035 SP08 Roshan Priyantha Emerging Antimicrobial Resistance among Staphylococcus Pseudintermedius, a Potential Zoonoses of Canine Origin

0036 SP09 Anthony Bai Positive Impact of Infectious Disease Consultation on Quality of Care, Mortality and Length of Stay in Staphylococcus aureus Bacteremia: Results from a Large Multicenter Cohort Study

0040 SP10 Carla Penney Prospective Observational Study of Diagnosis of Urinary Tract Infection and Response to Therapy in Long Term Care

0045 SP11 Jasmine Chong Molecular Epidemiology of Vancomycin Heteroresistant Coagulase-Negative Staphylococci in a Neonatal Intensive Care Unit in Quebec

0046 SP12 Sylvain Lother Increasing Incidence of Group C and Group G Streptococcal Bacteremia Attributed to Increased Bacterial Virulence Factors and Poor Outcomes

0047 SP13 Manal Rostom Antimicrobial Stewardship in Primary Care: An Evaluation of the Management of Acute Uncomplicated Cystitis in a Family Health Team

0048 SP14 Withdrawn 0049 SP15 Mohammad Alghounaim Clostridium difficile Infections (CDI) in Children: Are we

overestimating rates just because of the diagnostic method used?

0051 SP16 Sumana Fathima Surveillance of Human Parainfluenza Types 1-4 and Association with Acute Lower Respiratory Tract Infections in Hospitalized Cases, Alberta, Canada (2010 – 2013)

0052 SP17 Nathan Zelyas Clostridium difficile infection in solid organ transplant recipients at a tertiary care centre during 2006-2013

0056 SP18 Constantina Boikos Safety of the Live-Attenuated Intranasal Influenza Virus (LAIV) Vaccine in Children and Adolescents with Cystic Fibrosis and their Healthy Siblings

Revised April 7, 2015 Page 2 of 6

Serial No. Prog. No. Initial Last name Title 0058 SP19 Jianbo Zhang Severe Skin Lesions Induced by a Predominant CA-MRSA Strain

USA300 are Associated with a Unique Neutrophil Response and Involvement of Proteinase Activated Receptors (PARs)

0060 SP20 Élise Fortin Surveillance of Antimicrobial Use in Québec Acute Care Hospitals: A Dream or Almost Reality?

0065 SP21 Kristin Y. Popiel Usefulness of Fecal Calprotectin and Serum Procalcitonin in Predicting a Positive C. difficile Toxin Gene Polymerase Chain Reaction Assay

0066 SP22 Diana Whellams Successful use of intrathecal colistin in a case of Pseudomonas aeruginosa ventriculitis: a case report and brief review of the literature

0068 SP23 Geoffrey Shumilak Prevalence of Anemia in the Saskatchewan Population with HIV Infection

0073 SP24 Yan Chen Rapid Identification of Bacteria in Positive Blood Cultures Using Smudge Plate Preparation and MALDI-TOF MS System

0077 SP25 Chris Le Assessment of the management of suspected urinary tract infections for identification of targeted antimicrobial stewardship interventions

0078 SP26 Lauren Goodliffe Clinical Features and Outcomes of Influenza Infection in Community Dwelling Older Adults Presenting to Six Urban Emergency Departments

0080 SP27 Derek R. MacFadden Engaging Infectious Diseases And Microbiology Residents in Improving the Value of Healthcare: Choosing Wisely

0082 SP28 Luke Ryan Incidence and Outcomes of Hospital-acquired C. difficile Infection at a Large Community Hospital Before and After a Multipronged Prevention and Management Initiative

0084 SP29 Andrew Denisuik The Continued Rise of Extended-Spectrum β-Lactamase-Producing Escherichia coli in Canadian Hospitals: CANWARD 2007-2013

0085 SP30 Samuel De L’Étoile-Morel

Inpatient Care of Community Acquired Pneumonia: Opportunities for Improvement

0086 SP31 Yannick Emond Feasibility of UV-C light disinfection in a Canadian hospital. 0089 SP32 Sneha Suresh Non-Polio Enterovirus Types Associated with Acute Flaccid

Paralysis – A Systematic Review 0090 SP33 Shazia Masud Evaluation of Matrix Assisted Laser Desorption Ionization-Time

of Flight Mass Spectrometry (MALDI-TOF MS) for Yeast Identification

0091 SP34 Erika Koeck Xpert MTB/RIF as a Supplemental Test to Acid-Fast Bacilli Sputum Microscopy in the Diagnosis of Tuberculosis: Potential Resource Savings

0092 SP35 Alexandra Mcfarlane Hospitalized Influenza Patients during 2013-2014; a Comparison of ICU and Ward Treated Patients including Antimicrobial Therapy, Adverse Events, and Outcomes

0094 SP36 Galit Pomeranz Clinical Spectrum of Rhinovirus Infections in Hospitalized Children in Israel - a single center's experience

0098 SP37 David Harris Prosthetic Joint Infections: Patterns of Practice for Diagnosis, Management, and Outcome

Revised April 7, 2015 Page 3 of 6

Serial No. Prog. No. Initial Last name Title 0100 SP38 Emilie Vallieres Urinary Biomarkers in Patients with Cystic Fibrosis 0101 SP39 Amy Delorme Carbon Source Modulates Paradoxical Growth Effect of

Caspofungin in Candida albicans 0103 SP40 Hilal Al Sidairi Cost-effectiveness of MALDI-TOF MS in Clinical Analysis of Urine

Specimens in Nova Scotia 0150 SP41 Claudia Martinez de

la Peña Role of Type IV Pili in the Clostridium difficile Pathogenic Program

0121 SP42 Byron Berenger Detection and Characterization of a 2014 Escherichia coli O157:H7 Outbreak in Alberta by Multiple Molecular Methods Including Whole Genome Sequencing

0125 SP43 Angela Ma Heat Resistant Shiga Toxin-Producing Escherichia coli (STEC) from Clinical Cases in Alberta

0127 SP44 Dahn Jeong The Use of Antibiotics in the Treatment of Skin and Soft Tissue Infections in Selected First Nations Communities

0131 SP45 Alexander Lawandi The Role of Inter-Hospital Sample Transport in Total Assay Time for Microbiological Screening Tests

0137 SP46 Cindy Lam Investigation of Matrix Assisted Laser Desorption/Ionisation Time-of-Flight Mass Spectrometry (MALDI-TOF MS) for detection of Clostridium difficile toxin A and B from stool samples

0139 SP47 Aaron Campigotto Cumulative antimicrobial susceptibility data from ICUs at one institution: should data be combined?

0144 SP48 Gauri Shah Infectious Complications After Central Venous Catheter Repair in Pediatric Patients

0145 SP49 William J. Connors Acute Odontogenic Infection Management in the OPAT Clinic Setting: a Quality Improvement Study in Calgary, Alberta

Revised April 7, 2015 Page 4 of 6

POSTER PRESENTATION ASSIGNMENT LIST Serial No.

Prog. No.

Initial Last name Title

0005 P01 Nawal Al Musayeib Antiprotozoal potential of phenolic compounds from Kleinia odora

0006 P02 Adrian Shephard In-vitro Antiviral Action of Amylmetacresol (AMC) and 2,4-Dichlorobenzyl Alcohol (BCDA) Against the Respiratory Pathogen Parainfluenza Type 3

0011 P03 Barbara M. Willey Use of Temocillin Resistance (TemR) as a Phenotypic Diffusion Marker for Class D Carbapenemases (Carb) in Carbapenemase-Producing Organisms (CPO)

0015 P04 Withdrawn 0017 P05 Valan Arasu Mariadhas Novel Isosteviol Isolated From Pittosporum tetraspermum

Exhibited Antimicrobial, Antibiofilm And Anticancer Activities 0022 P06 Maheen Abidi CYP2C19*17 Genetic Polymorphism and Therapeutic Challenges

in an Allogeneic Stem Cell Transplant Recipient with Invasive Pulmonary Aspergillosis

0029 P07 Carole Lavigne Nanoparticles to Target HIV Reservoirs 0033 P08 Michael McConnell Increased Recovery and Detection of Pathogens Using Copan’s

WASPLab™ Total Laboratory Automation (TLA) 0037 P09 Anthony Bai Usefulness of previous methicillin-resistant Staphylococcus

aureus screening results in guiding empiric therapy for S. aureus bacteremia

0039 P10 Neal Irfan Inadequate Symptom Documentation of Urinary Tract Infection in the Medical Chart

0041 P11 Khurram Rana All-Oral 12-Week Combination Treatment with Daclatasvir (DCV) and Sofosbuvir (SOF) in Patients Infected with HCV Genotype (GT) 3: ALLY-3 Phase 3 Study

0043 P12 Eugene S. Swenson All-oral, Fixed-dose Combination Therapy with Daclatasvir/Asunaprevir/BMS-791325 for Non-cirrhotic Patients with Chronic HCV Genotype 1 Infection: UNITY-1 Phase 3 SVR12 Results

0044 P13 Eugene S. Swenson All-oral Fixed-dose Combination Therapy with Daclatasvir/Asunaprevir/BMS-791325, ± Ribavirin, for Patients with Chronic HCV Genotype 1 Infection and Compensated Cirrhosis: UNITY-2 Phase 3 SVR12 Results

0053 P14 Hong Yuan Zhou Recurrent Micafungin-Resistant Candida glabrata Candidemia with Prolonged Micafungin Treatment for Multiple Intra-abdominal Abscesses: A Case Report

0054 P15 Min-Kuang Lee Active Environmental Surveillance of Lyme Disease in British Columbia (2013 and 2014)

0055 P16 Ramzi Fattouh Investigating the Potential Role of Bacterial Infection in Granulomatosis with Polyangiitis (GPA)

0118 P17 Paul N. Levett Evaluation of antigen detection for confirmatory testing of hepatitis C virus infection

0149 P18 Kathleen Whyte Recurrent Invasive Haemophilus influenzae Type a Infection in an Infant

0072 P19 Muhammad Rehan Optimizing the Diagnostic Yield of Joint Fluid/ Tissue Culture for

Revised April 7, 2015 Page 5 of 6

Serial No.

Prog. No.

Initial Last name Title

the Hamilton Regional Laboratory Medicine Program 0097 P20 Jason Leblanc Pushing the Limits of Chemistry Point-of-Care Testing for the

Management of Patients under Investigation for Ebola Virus Disease

0099 P21 Melissa Kissoon Increase in Methicillin-susceptible Staphylococcus aureus with Reduced Susceptibility to Triclosan Over the Last 20 Years

0109 P22 Tony Mazzulli Characterizing the resistance related mutations in the NS3 protease of Hepatitis C-infected Ontario patients.

0114 P23 Kimberley Savage Iron Restriction to Clinical Isolates of Candida albicans by DIBI Inhibits Growth and Increases Sensitivity to Azole Antifungals

0062 P24 Withdrawn 0122 P25 Sarah West SNAP—Sepsis Now a Priority: Development and Implementation

of a Sepsis Algorithm in the Emergency Department of an Academic Hospital

0134 P26 Vanessa Meier-Stephenson

What a Fluke: A Case of Biliary Fascioliasis in a Recent Immigrant

0135 P27 Joel Kettner AMR, Public Health, and Knowledge Translation: A Forward Approach

0146 P28 Mary Louise Graham Oversight of Human and Animal Pathogens and Toxins P29 Withdrawn

0018 P30 Kamran Kadkhoda The Retrospective Study of the Prevalence and Clinical Significance of Hepatitis B Virus Precore and Basal Core Promoter Variants

0107 P31 Rabee Adwan Mycoplasma pneumoniae Infection in Children Less Than Five Years of Age; a 17 Years Review

0048 P32 Caroline Quach Emergency Department Utilization of Respiratory Virus Testing for Febrile Young Infants Under Six Weeks of Age

Revised April 7, 2015 Page 6 of 6

INNOVATION ACADEMY POSTER PRESENTATION LIST Serial No.

Prog. No.

Initial Last name Title

IA01 Patrick Dolcé Real-Time Computer-Generated Alerts to Select Interventions and Optimize an Antimicrobial Stewardship Program

IA02 Candy Rutherford Inclusion of Rhinovirus/Enterovirus in Routine Respiratory Testing Enabled Timely Detection of Enterovirus D68 in the Hamilton Area

IA03 Yanal M. Murad Preventing C. difficile Infection by Screening Hospital Admissions for C. difficile

CLINICAL VIGNETTE POSTER PRESENTATION LIST

Serial No.

Prog. No.

Initial Last name Title

Cv01 Syed Ala Adenovirus Interstitial Nephritis in a Patient with Renal Transplant

CV02 Glenn Patriquin A Case of Capnopytophaga canimorsus Meningitis CV03 Withdrawn CV04 Titus Wong Atypical Case of Atypical Pneumonia: Disseminated Mycoplasma

hominis Infection in a Double Lung Transplant Recipient